Cronos Group Inc. CRON

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $3.16
Market Cap $1.18B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑24.6% YoY
$146.59M
3-Yr CAGR: 16.8%
Net Income ↓-123.0% YoY
-$9.45M
Net Margin: -6.4%
Free Cash Flow ↓-97.7% YoY
$149.00K
FCF Yield: 0.01%
EPS (Diluted) ↓-118.2% YoY
$-0.02
Basic: $-0.02
Return on Equity Efficiency
-0.9%
ROA: -0.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CRON)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $0.9M $0.5M $-1.2M $-6.5M $-8.0M
FY 2017 $9.0M +868.6% $2.3M $2.5M +309.3% $-5.5M $-48.2M -503.2%
FY 2018 $16.3M +81.7% $11.3M $-19.2M -871.0% 0.00% $-9.7M $-124.1M -157.3%
FY 2019 $23.8M +45.6% $-17.9M $1,166.5M +6,174.0% $3.33 0.00% $-130.0M $-168.7M -35.9%
FY 2020 $46.7M +96.7% $-25.8M $-73.1M -106.3% $-0.21 -106.3% 0.00% $-142.5M $-173.9M -3.1%
FY 2021 $74.4M +59.3% $-17.5M $-396.1M -441.6% $-1.07 -409.5% 0.00% $-153.6M $-164.8M +5.2%
FY 2022 $91.9M +23.5% $12.0M $-168.7M +57.4% 0.00% $-88.9M $-92.4M +43.9%
FY 2023 $87.2M -5.1% $11.9M $-74.0M +56.2% $-0.19 0.00% $-42.8M $-45.3M +50.9%
FY 2024 $117.6M +34.8% $25.2M $41.1M +155.5% $0.11 +157.9% 0.00% $18.8M $6.4M +114.2%
FY 2025 $146.6M +24.6% $62.8M $-9.4M -123.0% $-0.02 -118.2% 0.00% $25.9M $0.1M -97.7%
$

Valuation

Market Price $3.16
Market Cap $1.18B
Enterprise Value $388.98M
P/E Ratio N/A
P/B Ratio 1.08
FCF Yield 0.01%
Dividend Yield N/A
Shares Outstanding 373,662,000
%

Profitability & Margins

Gross Margin 42.81%
Operating Margin -11.87%
Net Margin -6.44%
Return on Equity (ROE) -0.86%
Return on Assets (ROA) -0.79%
Asset Turnover 0.12x
Revenue 3-Yr CAGR 16.84%
🛡️

Financial Health & Liquidity

Current Ratio 19.59
Cash Ratio 16.43
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $791.79M
Total Debt N/A
Book Value / Share $2.93
💧

Cash Flow Efficiency

Operating Cash Flow $25.87M
Capital Expenditures (CapEx) $25.72M
Free Cash Flow $149.00K
OCF / Revenue 17.65%
FCF / Revenue 0.10%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.02
EPS (Basic) $-0.02
Dividends / Share N/A
Book Value / Share $2.93
EPS YoY Growth -118.18%
🏛️

Balance Sheet (FY 2025)

Total Assets $1.20B
Total Liabilities $54.18M
Stockholders' Equity $1.09B
Current Assets $944.09M
Current Liabilities $48.19M